CLINICAL AND COST OUTCOMES OF TREATMENT WITH INSULIN GLARGINE VERSUS INSULIN DETEMIR IN INSULIN NAïVE TYPE 2 DIABETES PATIENTS- COST-EFFECTIVENESS ANALYSIS IN THE KAZAKHSTAN SETTING
May 1, 2016, 00:00
10.1016/j.jval.2016.03.1303
https://www.valueinhealthjournal.com/article/S1098-3015(16)01371-1/fulltext
Title :
CLINICAL AND COST OUTCOMES OF TREATMENT WITH INSULIN GLARGINE VERSUS INSULIN DETEMIR IN INSULIN NAïVE TYPE 2 DIABETES PATIENTS- COST-EFFECTIVENESS ANALYSIS IN THE KAZAKHSTAN SETTING
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01371-1&doi=10.1016/j.jval.2016.03.1303
First page :
A203
Section Title :
Diabetes/Endocrine Disorders - Cost Studies
Open access? :
No
Section Order :
640